Lifecare ASA (OSL:LIFE)

Market Cap	131.51M
Revenue (ttm)	2.83M
Net Income (ttm)	-74.31M
Shares Out	19.06M
EPS (ttm)	-4.58
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	155,851
Average Volume	120,460
Open	6.62
Previous Close	7.00
Day's Range	6.62 - 7.56
52-Week Range	4.04 - 23.50
Beta	-0.35
RSI	37.60
Earnings Date	Nov 12, 2025

About Lifecare ASA

Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures pressure, temperature, force, or various other performance indicators in live tissue; and medical devices that remove subdermal implants. Lifecare ASA ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 39
• Stock Exchange: Oslo Børs
• Ticker Symbol: LIFE

Financial Performance

In 2024, Lifecare ASA's revenue was 9.67 million, a decrease of -26.10% compared to the previous year's 13.09 million. Losses were -71.76 million, 103.5% more than in 2023.